327 related articles for article (PubMed ID: 31001733)
1. Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells.
Yin X; Han S; Song C; Zou H; Wei Z; Xu W; Ran J; Tang C; Wang Y; Cai Y; Hu Q; Han W
Cell Oncol (Dordr); 2019 Aug; 42(4):459-475. PubMed ID: 31001733
[TBL] [Abstract][Full Text] [Related]
2. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Li Z; Liao J; Yang Z; Choi EY; Lapidus RG; Liu X; Cullen KJ; Dan H
Br J Cancer; 2019 Feb; 120(3):306-316. PubMed ID: 30585254
[TBL] [Abstract][Full Text] [Related]
3. CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15.
Liu Y; Chen X; Xu Y; Yang T; Wang H; Wang Z; Hu Z; Chen L; Zhang Z; Wu Y
J Mol Med (Berl); 2024 Jan; 102(1):81-94. PubMed ID: 37987774
[TBL] [Abstract][Full Text] [Related]
4. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
5. Metformin sensitizes hypoxia-induced gefitinib treatment resistance of HNSCC via cell cycle regulation and EMT reversal.
Yin X; Wei Z; Song C; Tang C; Xu W; Wang Y; Xie J; Lin Z; Han W
Cancer Manag Res; 2018; 10():5785-5798. PubMed ID: 30510448
[TBL] [Abstract][Full Text] [Related]
6. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis.
Inamoto S; Itatani Y; Yamamoto T; Minamiguchi S; Hirai H; Iwamoto M; Hasegawa S; Taketo MM; Sakai Y; Kawada K
Clin Cancer Res; 2016 Jan; 22(2):492-501. PubMed ID: 26341919
[TBL] [Abstract][Full Text] [Related]
7. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
Tariq M; Zhang JQ; Liang GK; He QJ; Ding L; Yang B
Acta Pharmacol Sin; 2017 Nov; 38(11):1501-1511. PubMed ID: 29022575
[TBL] [Abstract][Full Text] [Related]
8. CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion.
Li Y; Wu J; Zhang P
Tumour Biol; 2016 Apr; 37(4):4501-7. PubMed ID: 26501423
[TBL] [Abstract][Full Text] [Related]
9. Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages.
Ding L; Liang G; Yao Z; Zhang J; Liu R; Chen H; Zhou Y; Wu H; Yang B; He Q
Oncotarget; 2015 Nov; 6(34):36441-55. PubMed ID: 26497364
[TBL] [Abstract][Full Text] [Related]
10. Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15.
Huang FJ; Zhou XY; Ye L; Fei XC; Wang S; Wang W; Ning G
BMC Cancer; 2016 Feb; 16():98. PubMed ID: 26875556
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin Prevents Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Inhibiting Polarization of Macrophages in Tumor Microenvironment.
Chen R; Lu X; Li Z; Sun Y; He Z; Li X
Onco Targets Ther; 2020; 13():3375-3387. PubMed ID: 32425545
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
13. RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma.
Dan H; Liu S; Liu J; Liu D; Yin F; Wei Z; Wang J; Zhou Y; Jiang L; Ji N; Zeng X; Li J; Chen Q
Mol Oncol; 2020 Apr; 14(4):795-807. PubMed ID: 31997535
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages.
Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X
Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670
[TBL] [Abstract][Full Text] [Related]
15. Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling.
Chiang CF; Chao TT; Su YF; Hsu CC; Chien CY; Chiu KC; Shiah SG; Lee CH; Liu SY; Shieh YS
Oncotarget; 2017 Mar; 8(13):20706-20718. PubMed ID: 28157701
[TBL] [Abstract][Full Text] [Related]
16. NF-κB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-κB/Snail signaling in bladder cancer cells.
Zhang Q; Mao Z; Sun J
Gene; 2019 Aug; 710():91-97. PubMed ID: 31002892
[TBL] [Abstract][Full Text] [Related]
17. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
18. Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma.
Gao L; Zhang W; Zhong WQ; Liu ZJ; Li HM; Yu ZL; Zhao YF
Oncol Rep; 2018 Nov; 40(5):2558-2572. PubMed ID: 30132555
[TBL] [Abstract][Full Text] [Related]
19. M1 macrophage-derived exosomes and their key molecule lncRNA HOTTIP suppress head and neck squamous cell carcinoma progression by upregulating the TLR5/NF-κB pathway.
Jiang H; Zhou L; Shen N; Ning X; Wu D; Jiang K; Huang X
Cell Death Dis; 2022 Feb; 13(2):183. PubMed ID: 35210436
[TBL] [Abstract][Full Text] [Related]
20. Macrophages modulate migration and invasion of human tongue squamous cell carcinoma.
Pirilä E; Väyrynen O; Sundquist E; Päkkilä K; Nyberg P; Nurmenniemi S; Pääkkönen V; Pesonen P; Dayan D; Vered M; Uhlin-Hansen L; Salo T
PLoS One; 2015; 10(3):e0120895. PubMed ID: 25811194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
